News & Updates

In the treatment of patients with type 2 diabetes (T2D) and obesity, metabolic/bariatric surgery appears to produce sustained weight loss over 12 years, translating to better physical function, general health, and vitality, as well as reduced pain, according to long-term data from the ARMMS-T2D Study.

Poor glycaemic control appears to contribute to coronary stent failure driven by in-stent restenosis in patients with type 2 diabetes (T2D), suggests a study.

New research has shown that a low-fat vegan diet rich in vegetables, fruits, whole grains, and legumes can improve insulin sensitivity in adult patients with type 1 diabetes (T1D), thus reducing their daily insulin requirements. The finding may fuel the momentum for dietary shifts in this population.

Semaglutide reduces the risk of major kidney disease-related events and death from cardiovascular causes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as shown in the FLOW* study presented at ERA 2024. 

Diabetic patients with primary open-angle glaucoma (POAG) are at greater risk of developing diabetic retinopathy (DR), reveals a study, noting the need for screening and comprehensive management in glaucomatous patients with diabetes to reduce the risk of DR.